C07K 1 - General processes for the preparation of peptides

Patents for C07K 1 - General processes for the preparation of peptides (51,718)
11/1999
11/10/1999	CN1234804A Process for preparing pharmacologically acceptable salts of N-(1-(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl amino acids
11/10/1999	CN1046292C Method of chemical dressing hemoglobins used as oxygen carrier in blood substitution material
11/09/1999	US5981718 Polypeptide with reduced allergenicity
11/09/1999	US5981716 Process for the purification of proteins
11/09/1999	US5981715 Pretreating alpha-1-antitrypsin solution with a sugar before viral deactivation with solvent-detergent treatment; purifying product known as tradename aralast np
11/09/1999	US5981709 Conjugating an acid stable alpha-interferon with an activated non-antigenic polymer in solution, acidifying solution to selectively cleave linkages that reduce bioactivity, adjust solution to a physiological ph
11/09/1999	US5981701 Tumor necrosis factor inhibitory protein and its purification
11/09/1999	US5981474 Solubilization of pharmaceutical substances in an organic solvent and preparation of pharmaceutical powders using the same
11/09/1999	US5981467 Containing quatenary nitrogen unit
11/09/1999	US5981277 Polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
11/09/1999	US5981254 Salting out plasma proteins, diafiltering and diluting supernatant containing prothrombin, acidic precipitation, solubilizing, converting to thrombin, deactivating lipid containing viruses, chromatographic purification; safe glues
11/09/1999	US5981170 Diagnostic immunoassay kit for detection of antibodies induced by human immunodeficiency virus in sample of body fluid; includes artificial peptide of an epitope having a cystine bridge
11/09/1999	US5980861 Chelator compositions and methods of synthesis thereof
11/09/1999	US5980839 A reaction region comprising a plurality of individual reaction cavities, each having an aperture to supply or remove reagents, solvents, gases and vacuum suction for conducting automatic combinatorial chemical synthese
11/04/1999	WO1999055899A1 Methods for transducing fusion molecules
11/04/1999	WO1999055718A2 Solution phase biopolymer synthesis
11/04/1999	WO1997049812A3 Process for extracting and purifying recombinant, non-lipidised osp-protein
11/04/1999	CA2330560A1 Methods for transducing fusion molecules
11/03/1999	EP0953835A1 Apparatus for detection of a fluorescence pattern corresponding to ligand binding on a substrate
11/03/1999	EP0953577A1 Procedure for obtaining the somatostatin analog, octreotide
11/03/1999	EP0953573A2 Pentapeptide with specific conformation, its production and use
11/03/1999	EP0953572A2 Peptides binding to bone marrow stromal cell antigen
11/03/1999	EP0953053A2 Viral particles which are masked or unmasked with respect to a cell receptor
11/03/1999	EP0952981A1 Method for producing a correctly folded, biological active recombinant protein
11/03/1999	EP0952980A1 Acyl transfer with stabilised transition complex using catalyst with catalytic imidazole (e.g. histidine) function
11/03/1999	EP0655069B1 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems
11/03/1999	CN1234078A Compositions and method for treating viral infections
11/02/1999	US5977324 Process for concentrating protein with disease-related conformation
11/02/1999	US5977301 Synthesis of N-substituted oligomers
11/02/1999	US5977299 Peptide having terminal activating group; for sensitive diagnostics; therapy
11/02/1999	US5977297 Loading pressure-stable acidic cation exchange column with sample solution, performing chromatography under pressure of 1.1 mpa to 40 mpa, eluting insulin from column; no further purification step necessary
11/02/1999	US5977296 Chiral peptide nucleic acid monomers and oligomers
11/02/1999	US5976861 Proteins for the isolation of antibodies.
11/02/1999	US5976840 Polynucleotides encoding gluS polypeptides of streptococcal pneumoniae
11/02/1999	US5976597 Basic protein composition, basic peptide composition and application thereof
11/02/1999	US5976529 Methods of enzyme therapy by orally administering crosslinked enzyme crystals
11/02/1999	US5976492 Radioactive phosphorus labeled proteins for targeted radiotherapy
11/02/1999	US5976382 Crosslinking an olefin or alkyl vinyl ether-maleic anhydride copolymer with a diamine. separation of protein/polymer matrix with sodium dodecyl sulfate.
11/02/1999	US5976381 Chromatographic purification of cyclosporing using a high pressure carbon dioxide eluent
11/02/1999	CA1340810C Polypeptide derivatives of human granulocyte colony stimulating factor
10/1999
10/28/1999	WO1999054784A1 Free-form nanofabrication using multi-photon excitation
10/28/1999	WO1999054735A1 Improved immunodiagnostic assays using reducing agents
10/28/1999	WO1999054728A2 Method of predicting receptor modulating activity
10/28/1999	WO1999054355A1 Process for the recovery and purification of a recombinant protein from a cell
10/28/1999	WO1999053946A1 Modifications of antigens by the introduction of aldehyde groups and their use in enhancing the immune response
10/28/1999	WO1999039817A9 Method of quality control in manufacturing processes
10/28/1999	WO1999025724A3 Oligonucleotide synthesis using high boiling point solvents
10/28/1999	CA2658218A1 Improved immunodiagnostic assays using reducing agents
10/28/1999	CA2329302A1 Modifications of antigens by the introduction of aldehyde groups and their use in enhancing the immune response
10/28/1999	CA2269103A1 Peptides binding to bone marrow stromal cell antigen
10/27/1999	EP0167575B2 Cardiodilatine, a peptide hormone and production process thereof
10/27/1999	CN1233255A Preparation of purified (poly) peptides
10/26/1999	USRE36359 Long chain carboxylic acid imide ester
10/26/1999	US5973123 Monoclonal antibody, or fragment thereof, which has an affinity for native melanoma inhibitory activity protein
10/26/1999	US5973118 A polypeptide which codes a trypsin inhibitor; for purification of tissue plasminogen activators
10/26/1999	US5973114 Isolated purified growth hormone releasing hormone (ghrh) receptor of given molecular weight; made by solubilization of ghrh-r/ghrh complexes and extraction of bound ghrh using mild detergent followed by affinity chromatography
10/26/1999	US5973113 Hypusine reagent for peptide synthesis
10/26/1999	US5972896 Antiangiogenic peptides and methods for inhibiting angiogenesis
10/26/1999	US5972886 Amino acid sequences, a gene coding for stimulating cell differentiation of megakaryocytes; increasing blood platelet cells
10/26/1999	US5971158 Laminar flow
10/26/1999	CA2029678C Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 14
10/21/1999	WO1999053310A1 Antigen
10/21/1999	WO1999052946A1 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses
10/21/1999	WO1999052934A1 NOVEL PROCESS FOR THE SEPARATION OF PROTEINS USING A Ca++ CONTAINING ELUANT
10/21/1999	WO1999052933A1 Process for the preparation of resin-bound cyclic peptides
10/21/1999	WO1999042474A3 Method for designing dna-binding proteins of the zinc-finger class
10/21/1999	WO1999032428A8 Synthesis of diamines
10/21/1999	WO1999009416A3 Method of drug selection
10/21/1999	CA2327882A1 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses
10/21/1999	CA2325572A1 Process for the preparation of resin-bound cyclic peptides
10/20/1999	EP0950112A1 Photolabile polymer array synthesis methods
10/20/1999	EP0950067A1 Affinity purification of polypeptide on protein a matrix
10/20/1999	EP0950045A2 A solid-phase technology for the preparation of amides
10/20/1999	EP0765307B1 N alpha-2-(4-nitrophenylsulfonyl)ethoxycarbonyl-amino acids
10/20/1999	CN1232038A New peptide compounds, process for their preparation and pharmaceutical compositions containing them
10/19/1999	US5969095 Analogs of parathyroid hormone
10/19/1999	US5968834 Reacting peptide/protein with acid chloride derivative under acidic conditions; then with organic salt thiocyanate, organic isothiocyanate, alkali or alkaline earth metal salt isothiocyanate forming terminal thiohydantoin amino acid
10/19/1999	US5968776 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
10/19/1999	US5968753 Peptides which displace a monoclonal antibody bound to a cell surface antigen on a target cell; for separating specific cells like cd34 positive hematopoeitic stem cells from a heterogeneous cell population
10/19/1999	US5968736 Methods for recording the reaction history of a solid support
10/19/1999	US5968477 Radiolabeled annexin conjugates with hexose and a chelator
10/14/1999	WO1999051638A1 DUAL Avb3 AND METASTASIS-ASSOCIATED RECEPTOR LIGANDS
10/14/1999	WO1999051626A2 Template associated npy y2-receptor agonists
10/14/1999	WO1999051625A2 Peptides causing formation of compact structures
10/14/1999	WO1999051279A1 A method for treating contaminated products and articles
10/14/1999	WO1999042076A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/14/1999	WO1999040188A3 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccinations
10/14/1999	WO1999028343A9 Hydrophobically-modified protein compositions and methods
10/14/1999	CA2577543A1 Antibody variants and fragments thereof
10/14/1999	CA2326146A1 Template associated npy y2-receptor agonists
10/14/1999	CA2325342A1 Dual avb3 and metastasis-associated receptor ligands
10/14/1999	CA2324284A1 Peptides causing formation of compact structures
10/13/1999	EP0949270A1 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
10/13/1999	EP0948540A2 Method for solubilization and naturation of somatotropins
10/13/1999	EP0948538A1 Analysis and separation of platelet-derived growth factor proteins
10/13/1999	EP0948535A1 Novel lanthionine antibiotic compositions and methods
10/13/1999	EP0948517A1 MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC TO THE MOLECULE, AND USES THEREOF
10/13/1999	EP0948344A1 Synthetic antibiotics
10/13/1999	EP0777678B1 Pna combinatorial libraries and improved methods of synthesis
10/13/1999	EP0733121A4 Method of synthesizing a fluorescently labeled protein

1 ... 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 ... 518